Showing 121-140 of 644 for: Cochrane Systematic Reviews > Respiratory 
- Colchicine as an oral corticosteroid sparing agent for asthma
Cochrane Systematic Reviews, 5-Nov-2009
Oral corticosteroids are used as a treatment for asthma, but they are often associated with serious side effects. Colchicine is an anti-inflammatory, immuno modulating agent, which could potentially have a beneficial effect in the treatment of asthma as w
- Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children
Cochrane Systematic Reviews, 12-Jul-2016
Traditionally inhaled treatment for asthma has used separate preventer and reliever therapies. The combination of formoterol and budesonide in one inhaler has made possible a single inhaler for both prevention and relief of symptoms (single inhaler therap
- Combination inhaled steroid and long‐acting beta2‐agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 6-Jun-2016
The long-acting bronchodilator tiotropium and single-inhaler combination therapy of inhaled corticosteroids and long-acting beta2-agonists (ICS/LABA) are commonly used for maintenance treatment of patients with chronic obstructive pulmonary disease (COPD)
- Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 30-Apr-2013
Combination therapy (inhaled corticosteroids and long-acting beta2-agonists) and tiotropium are both used in the treatment of chronic obstructive pulmonary disease (COPD). There is uncertainty about the relative benefits and harms of these treatments.
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 30-Aug-2013
Both long-acting beta2-agonists and inhaled corticosteroids have been recommended in guidelines for the treatment of chronic obstructive pulmonary disease (COPD). Their co-administration in a combined inhaler is intended to facilitate adherence to medicat
- Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonists for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 12-Apr-2013
Both inhaled steroids (ICS) and long-acting beta2-agonists (LABA) are used in the management of chronic obstructive pulmonary disease (COPD). This updated review compared compound LABA plus ICS therapy (LABA/ICS) with the LABA component drug given alone.
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 10-Nov-2013
Both long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS) have been recommended in guidelines for the treatment of chronic obstructive pulmonary disease (COPD). Their coadministration in a combination inhaler may facilitate adherence to med
- Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children
Cochrane Systematic Reviews, 4-Sep-2013
There are several treatment options for managing acute asthma exacerbations (sustained worsening of symptoms that do not subside with regular treatment and require a change in management). Guidelines advocate the use of inhaled short acting beta2-agonists
- Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children
Cochrane Systematic Reviews, 21-Aug-2017
Strong evidence supports the use of metered-dose inhalers combined with a spacer for delivering rapid-acting inhaled beta-2 agonists in the treatment of acute exacerbations of asthma in children. The high cost and lack of availability of commercially prod
- Concurrent chemoradiotherapy in non-small cell lung cancer
Cochrane Systematic Reviews, 5-May-2010
This is an updated version of the original review published in Issue 4, 2004. The use of concurrent chemotherapy and radiotherapy in non-small cell lung cancer (NSCLC) might be seen as a way of increasing the effectiveness of radical radiotherapy at the s
- Conjugate vaccines for preventing Haemophilus influenzae type B infections
Cochrane Systematic Reviews, 21-Jul-2009
Haemophilus influenzae (H. influenzae) is an important cause of meningitis and pneumonia in children. Vaccine cost is a significant barrier to use in low income countries. Determining the size of the effects of the vaccine will enable cost-effectiveness c
- Continuous nasogastric milk feeding versus intermittent bolus milk feeding for preterm infants less than 1500 grams
Cochrane Systematic Reviews, 24-Jun-2021
Milk feedings can be given via nasogastric tube either intermittently, typically over 10 to 20 minutes every two or three hours, or continuously, using an infusion pump. Although the theoretical benefits and risks of each method have been proposed, their
- Continuous negative extrathoracic pressure or continuous positive airway pressure compared to conventional ventilation for acute hypoxaemic respiratory failure in children
Cochrane Systematic Reviews, 11-Nov-2013
Acute hypoxaemic respiratory failure (AHRF) is an important cause of mortality and morbidity in children. Positive pressure ventilation is currently the standard care, however, it does have complications. Continuous negative extrathoracic pressure (CNEP)
- Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants
Cochrane Systematic Reviews, 15-Oct-2020
Respiratory distress, particularly respiratory distress syndrome (RDS), is the single most important cause of morbidity and mortality in preterm infants. In infants with progressive respiratory insufficiency, intermittent positive pressure ventilation (IP
- Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea
Cochrane Systematic Reviews, 18-Oct-2006
Continuous positive airway pressure (CPAP) is the mainstay of therapy for moderate to severe obstructive sleep apnoea (OSA). However, compliance with CPAP has been less than ideal. There are many different CPAP interfaces now available for the treatment o
- Continuous positive airway pressure versus theophylline for apnea in preterm infants
Cochrane Systematic Reviews, 29-Oct-2008
Recurrent apnea is common in preterm infants, particularly at very early gestational ages. These episodes of loss of effective breathing can lead to hypoxemia and bradycardia which may be severe enough to require resuscitation including use of positive pr
- Continuous positive airways pressure for obstructive sleep apnoea in adults
Cochrane Systematic Reviews, 19-Jul-2006
Obstructive sleep apnoea is the periodic reduction (hypopnoea) or cessation (apnoea) of breathing due to narrowing or occlusion of the upper airway during sleep. The main symptom is daytime sleepiness and it has been suggested it is linked to premature de
- Continuous versus intermittent beta‐agonists for acute asthma
Cochrane Systematic Reviews, 20-Oct-2003
Patients with acute asthma treated in the emergency department are frequently treated with intermittent inhaled beta-agonists delivered by nebulisation. The use of continuous beta-agonist (CBA) via nebulisation in the emergency setting may offer additiona
- Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis
Cochrane Systematic Reviews, 24-Jan-2005
Cystic fibrosis is an inherited life-limiting disorder, characterised by pulmonary infections and thick airway secretions. Chest physiotherapy has been integral to clinical management in facilitating removal of airway secretions. Conventional chest physio
- Cooling for newborns with hypoxic ischaemic encephalopathy
Cochrane Systematic Reviews, 31-Jan-2013
Newborn animal studies and pilot studies in humans suggest that mild hypothermia following peripartum hypoxia-ischaemia in newborn infants may reduce neurological sequelae without adverse effects.
